Division of Interventional Radiology, S. Mark Taper Foundation Imaging Center, Cedars-Sinai Medical Center, Los Angeles, Calif.
Division of Interventional Radiology, S. Mark Taper Foundation Imaging Center, Cedars-Sinai Medical Center, Los Angeles, Calif.
J Vasc Surg Venous Lymphat Disord. 2018 Mar;6(2):163-172. doi: 10.1016/j.jvsv.2017.09.006. Epub 2017 Dec 9.
The purpose of this study was to retrospectively assess the retrieval characteristics and rate of filter-related complications associated with use of the Celect Platinum (Cook Medical, Bloomington, Ind) inferior vena cava filter (IVCF).
A single-center, retrospective review was conducted to identify patients who received a Celect Platinum IVCF between June 2013 and February 2016. The patients' charts and imaging records (computed tomography [CT] and cavography) associated with filter placement, follow-up, and filter retrieval procedures were assessed for attempted and successful retrieval rates and filter-related complications.
During the review period, 562 Celect Platinum filters were placed in 556 patients. Outcome and evaluable imaging data (CT and cavography) were available from 335 patients, with median CT follow-up time of 45 days (average, 126 days) and median cavography follow-up time of 90 days (average, 102 days). IVCF leg perforation of the inferior vena cava wall >3 mm was identified in 65 cases (19.4%) on follow-up imaging (64 cases). In addition, filter tilt >15 degrees was identified in 4 filters (1.2%), filter migration >2 cm in 1 filter (0.3%), and occlusive filter or inferior vena cava or iliac vein thrombus in 11 filters; no filter fracture was observed. One case of breakthrough pulmonary embolism and two additional indeterminate cases were identified on follow-up CT pulmonary angiography (2.6%-7.7%). Retrieval was successful in 155 of 155 patients (median indwell time, 90 days; range, 1-445 days); an advanced retrieval technique was used in 11 retrievals.
The outcomes for the Celect Platinum filter were comparable to those previously reported for the first-generation Celect filter in all categories assessed.
本研究旨在回顾性评估使用 Celect Platinum(库克医疗,印第安纳州布鲁明顿)下腔静脉滤器(IVCF)的检索特征和与滤器相关并发症的发生率。
进行了一项单中心回顾性研究,以确定 2013 年 6 月至 2016 年 2 月期间接受 Celect Platinum IVCF 的患者。评估患者的图表和与滤器放置、随访和滤器取出程序相关的影像学记录(计算机断层扫描[CT]和腔静脉造影),以评估尝试和成功取出率以及与滤器相关的并发症。
在审查期间,556 例患者中放置了 562 个 Celect Platinum 滤器。335 例患者的结果和可评估的影像学数据(CT 和腔静脉造影)可用,CT 随访中位时间为 45 天(平均 126 天),腔静脉造影随访中位时间为 90 天(平均 102 天)。在随访影像学检查中发现 65 例(19.4%)下腔静脉壁 IVCF 腿穿孔>3mm,4 例(1.2%)滤器倾斜>15 度,1 例(0.3%)滤器迁移>2cm,11 例(3.3%)出现闭塞性滤器或下腔静脉或髂静脉血栓形成,未观察到滤器断裂。在后续 CT 肺动脉造影中发现 1 例肺血栓栓塞症突破和另外 2 例不确定病例(2.6%-7.7%)。155 例中的 155 例(中位植入时间 90 天;范围 1-445 天)成功取出;11 例采用了高级取回技术。
在评估的所有类别中,Celect Platinum 滤器的结果与第一代 Celect 滤器的结果相当。